HNRNPA1P42

Across TCGA pan-cancer cohorts, HNRNPA1P42 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of HNRNPA1P42’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where HNRNPA1P42 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types HNRNPA1P42 is over-expressed in tumor.

COAD, LUAD, and BLCA are the cancer types where HNRNPA1P42 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in HNRNPA1P42 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.103	.001	7	view →
LUAD	All	III,IV	+0.134	.005	3	view →
BLCA	Male	III,IV	+0.128	.005	2	view →
STAD	All	All	+0.096	.031	2	view →
HNSC	Male	II,III,IV	+0.067	.034	2	view →
KIRC	Female	All	+0.055	.013	2	view →
READ	Female	All	+0.142	.023	1	view →
LIHC	Female	II,III,IV	+0.039	.044	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

HNRNPA1P42–COAD

Open the COAD breakdown →